Related Experiment Video

Updated: Oct 17, 2026

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies
09:03

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies

Published on: June 30, 2023

Loxosceles deserta spider venom induces the expression of vascular endothelial growth factor (VEGF) in keratinocytes

A Desai1, H A Lankford, J S Warren

  • 1Department of Pathology, University of Michigan Medical School, Ann Arbor 48109-0602, USA.

Inflammation
|March 7, 2000
PubMed

Insights

Loxosceles spider venom causes skin damage by triggering vascular endothelial growth factor (VEGF) production in skin cells. This suggests VEGF plays a role in the inflammation and swelling seen after a Loxosceles bite.

Area of Science:

  • Dermatology
  • Toxicology
  • Molecular Biology

Background:

  • Loxosceles spider envenomation commonly leads to severe necrotic skin lesions.
  • The precise cellular and molecular pathways driving lesion development are not fully understood.
  • Pro-inflammatory mediators are implicated in the pathogenesis of Loxosceles-induced skin damage.

Purpose of the Study:

  • To investigate the effect of Loxosceles deserta venom on vascular endothelial growth factor (VEGF) expression in human skin cells.
  • To determine which specific cell types within the skin are most responsive to Loxosceles venom regarding VEGF production.

Main Methods:

  • Exposure of human keratinocytes, smooth muscle cells, and pulmonary epithelial cells to Loxosceles deserta venom.
  • Quantification of VEGF mRNA levels using RNase protection assays.
  • Assessment of VEGF expression across different human cell lines.

Main Results:

  • Loxosceles deserta venom significantly induced vascular endothelial growth factor (VEGF) expression in human keratinocytes.
  • VEGF mRNA levels in keratinocytes increased notably within 2 hours of venom exposure.
  • Minimal VEGF induction was observed in smooth muscle cells, and none in pulmonary epithelial cells.

Conclusions:

  • Keratinocytes are a primary source of VEGF in response to Loxosceles deserta venom.
  • Keratinocyte-derived VEGF may contribute to the characteristic vasodilation, edema, and erythema following Loxosceles envenomation.
  • These findings elucidate a potential molecular mechanism underlying the inflammatory response to Loxosceles spider bites.

More Related Videos

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells11:13

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

Published on: April 7, 2016

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...